Literature DB >> 15907417

Off-pump coronary artery bypass grafting does not reduce lymphocyte activation.

C Blacher1, J Neumann, L A Jung, F A Lucchese, J P Ribeiro.   

Abstract

OBJECTIVE: In this study, we test the hypothesis that off-pump coronary bypass surgery might result in less lymphocyte activation than on-pump coronary surgery. We also study the behavior of lymphocyte activation markers during and after surgery.
BACKGROUND: Coronary artery bypass surgery is known to be associated with changes of inflammatory mediators, immune function, and early phase lymphocyte activation, which could cause postoperative lymphopenia and lymphocyte unresponsiveness.
METHODS: We studied lymphocyte activation response in 28 patients randomized to off-pump (n = 13) or on-pump (n = 15) coronary artery bypass surgery. Expression of CD25, CD26, CD69, and DR on T (CD3+) and B (CD19+) lymphocytes on peripheral blood was assessed through flow cytometry.
RESULTS: The response of T lymphocytes and their activation markers, as well as B lymphocytes and their activation markers, was similar after on- and off-pump surgery. Overall, T lymphocytes decreased to the lowest level 9 h after surgery and tended to increase later. For B lymphocytes, there was early reduction with increase on the 1st postoperative day. There was early activation of CD69+ and late activation of CD25+ on T lymphocytes. For B lymphocytes, there was early activation of CD69+ and late activation of DR+.
CONCLUSIONS: (1) Compared to on-pump cardiopulmonary bypass, off-pump surgery does not reduce lymphocyte activation. (2) Coronary bypass surgery causes the early activation of lymphocytes, as evidenced by the increased expression of lymphocyte activation markers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907417     DOI: 10.1016/j.ijcard.2004.07.006

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

Review 1.  A systematic review of the quality of publications reporting coronary artery bypass grafting trials.

Authors:  Forough Farrokhyar; Rong Chu; Richard Whitlock; Lehana Thabane
Journal:  Can J Surg       Date:  2007-08       Impact factor: 2.089

2.  Quantification of fat mobilization in patients undergoing coronary artery revascularization using off-pump and on-pump techniques.

Authors:  Ahmed Ajzan; Thomas Modine; Prakash Punjabi; Kandeepan Ganeshalingam; Gary Philips; Terence Gourlay
Journal:  J Extra Corpor Technol       Date:  2006-06

3.  A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.

Authors:  John H Stewart; Perry Shen; Greg Russell; Joyce Fenstermaker; Libby McWilliams; Faith M Coldrun; Keith E Levine; Bradley T Jones; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2008-05-21       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.